{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:55:28Z","timestamp":1789761328723,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["202-3486"],"award-info":[{"award-number":["202-3486"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101985","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:06:26Z","timestamp":1741003586000},"page":"101985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis"],"prefix":"10.1016","volume":"39","author":[{"given":"Ashutosh Kumar","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2025.101985_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101985_bib2","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib3","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocr-Relat Cancer"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4248\/BR201302005","article-title":"Primary hyperparathyroidism: a tale of two cities revisited - New York and Shanghai","volume":"1","author":"Liu","year":"2013","journal-title":"Bone Res"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40618-024-02464-6","article-title":"Prevalence, risk factors and effect of curative parathyroidectomy on nephrocalcinosis in Asian-Indian patients with symptomatic primary hyperparathyroidism","volume":"48","author":"Kumari","year":"2025","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.beem.2025.101985_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya","year":"2021","journal-title":"J Bone Miner Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101985_bib7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1530\/EC-21-0382","article-title":"Changes in clinical patterns of Chinese patients with primary hyperparathyroidism in the past 12 years: a single-center experience","volume":"10","author":"Liu","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2025.101985_bib8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol"},{"issue":"5311","key":"10.1016\/j.beem.2025.101985_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.beem.2025.101985_bib10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib11","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2032\u00e9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?","volume":"67","author":"Giusti","year":"2012","journal-title":"Clinics"},{"issue":"8","key":"10.1016\/j.beem.2025.101985_bib13","first-page":"2960","article-title":"Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism","volume":"83","author":"Carling","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101985_bib14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/BF03345303","article-title":"Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics","volume":"27","author":"Scarpelli","year":"2004","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.beem.2025.101985_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1098-1004(200011)16:5<445::AID-HUMU12>3.0.CO;2-6","article-title":"Six novel MEN1 gene mutations in sporadic parathyroid tumors","volume":"16","author":"Cetani","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.beem.2025.101985_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.834362","article-title":"Genetics and epigenetics of parathyroid carcinoma","volume":"13","author":"Marini","year":"2022","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2025.101985_bib17","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0479","article-title":"Clinical and molecular characterization of parathyroid carcinoma in multiple endocrine neoplasia type 1","volume":"12","author":"Lomelino Pinheiro","year":"2023","journal-title":"Endocr Connect"},{"issue":"12","key":"10.1016\/j.beem.2025.101985_bib18","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.beem.2025.101985_bib19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jbmr.4653","article-title":"Multilevel annotation of germline MEN1 variants of synonymous, nonsynonymous, and uncertain significance in Indian patients with sporadic primary hyperparathyroidism","volume":"37","author":"Kaur","year":"2022","journal-title":"J Bone Min Res"},{"issue":"1-2","key":"10.1016\/j.beem.2025.101985_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2009.08.020","article-title":"Regulation of vitamin D receptor function in MEN1-related parathyroid adenomas","volume":"313","author":"Dreijerink","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.101985_bib21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1677\/ERC-09-0082","article-title":"Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia","volume":"16","author":"Harding","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"22","key":"10.1016\/j.beem.2025.101985_bib23","first-page":"8022","article-title":"Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism","volume":"63","author":"Libutti","year":"2003","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.beem.2025.101985_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"issue":"5293","key":"10.1016\/j.beem.2025.101985_bib25","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-2143(96)90092-X","article-title":"Cyclin D1\/PRAD1 as a central target in oncogenesis","volume":"127","author":"Hosokawa","year":"1996","journal-title":"J Lab Clin Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib27","first-page":"412","article-title":"Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study","volume":"12","author":"Vasef","year":"1999","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib28","first-page":"N30","article-title":"Molecular pathogenesis of primary hyperparathyroidism","volume":"17","author":"Arnold","year":"2002","journal-title":"J Bone Min Res"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib29","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2010.132","article-title":"Parathyroid tumors and related disorders","volume":"24","author":"DeLellis","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.beem.2025.101985_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.beem.2025.101985_bib31","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/clinem\/dgad002","article-title":"Genomic profiling reveals the variant landscape of sporadic parathyroid adenomas in Chinese population","volume":"108","author":"Tao","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2025.101985_bib32","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00268-014-2455-9","article-title":"Copy number variation in CCND1 gene is implicated in the pathogenesis of sporadic parathyroid carcinoma","volume":"38","author":"Zhao","year":"2014","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-13-0085","article-title":"Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians","volume":"169","author":"Varshney","year":"2013","journal-title":"Eur J Endocrinol \/ Eur Fed Endocr Soc"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40618-019-01098-3","article-title":"Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors","volume":"43","author":"Arya","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"20","key":"10.1016\/j.beem.2025.101985_bib35","doi-asserted-by":"crossref","first-page":"11206","DOI":"10.3390\/ijms222011206","article-title":"Parathyroid tumors: molecular signatures","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.beem.2025.101985_bib36","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2025.101985_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.773143","article-title":"Case report: new CDKN1B mutation in multiple endocrine neoplasia type 4 and brief literature review on clinical management","volume":"13","author":"Lavezzi","year":"2022","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2025.101985_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12672-013-0147-9","article-title":"Germline and somatic mutations in cyclin-dependent kinase inhibitor genes CDKN1A, CDKN2B, and CDKN2C in sporadic parathyroid adenomas","volume":"4","author":"Costa-Guda","year":"2013","journal-title":"Horm Cancer"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib39","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41598-017-03143-8","article-title":"Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas","volume":"7","author":"Arya","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.beem.2025.101985_bib40","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/ijms23105378","article-title":"Histone modification on parathyroid tumors: a review of epigenetics","volume":"23","author":"Conti de Freitas","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2025.101985_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1180211","article-title":"Sporadic parathyroid adenoma: an updated review of molecular genetics","volume":"14","author":"Chorti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10.1016\/j.beem.2025.101985_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/gcc.20895","article-title":"The DNA methylome of benign and malignant parathyroid tumors","volume":"50","author":"Starker","year":"2011","journal-title":"Genes, Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.beem.2025.101985_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040328","article-title":"An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/\u03b2-catenin signaling","volume":"4","author":"Bj\u00f6rklund","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.beem.2025.101985_bib44","unstructured":"Juhlin C. Molecular Aspects of Parathyroid Tumorigenesis with Focus on Parafibromin and the WNT Pathway. Karolinska Institutet, Sweden."},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12022-020-09656-9","article-title":"Genomics and epigenomics in parathyroid neoplasia: from bench to surgical pathology practice","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009472","article-title":"Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours","volume":"5","author":"Juhlin","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2025.101985_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-04113-7","article-title":"Aberrant promoter methylation, expression and function of RASSF1A gene in a series of Italian parathyroid tumors","author":"Verdelli","year":"2024","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2025.101985_bib48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/epi.24823","article-title":"Global and gene-specific promoter methylation analysis in primary hyperparathyroidism","volume":"8","author":"Sulaiman","year":"2013","journal-title":"Epigenetics"},{"issue":"11","key":"10.1016\/j.beem.2025.101985_bib49","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1074\/jbc.275.11.7553","article-title":"Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas*","volume":"275","author":"Chikatsu","year":"2000","journal-title":"J Biol Chem"},{"issue":"6, Part B","key":"10.1016\/j.beem.2025.101985_bib50","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bbamcr.2015.11.017","article-title":"The calcium-sensing receptor and the hallmarks of cancer","volume":"1863","author":"Tennakoon","year":"2016","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Cell Res"},{"key":"10.1016\/j.beem.2025.101985_bib51","first-page":"lvae122","article-title":"mRNA expression of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic and asymptomatic primary hyperparathyroidism","author":"Kaur","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2025.101985_bib52","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1210\/clinem\/dgaa419","article-title":"Reduced calcium sensing receptor (CaSR) expression is epigenetically deregulated in parathyroid adenomas","volume":"105","author":"Singh","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101985_bib53","article-title":"Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control","author":"Massy","year":"2014","journal-title":"Pap Presente : Semin Nephrol"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.beem.2025.101985_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4158\/EP10325.RA","article-title":"Vitamin D receptors and parathyroid glands","volume":"17","author":"Landry","year":"2011","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.beem.2025.101985_bib56","first-page":"2255","article-title":"Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.","volume":"83","author":"Carling","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2025.101985_bib57","doi-asserted-by":"crossref","first-page":"E1631","DOI":"10.1210\/jc.2013-1699","article-title":"Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas","volume":"98","author":"Varshney","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","article-title":"Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis","volume":"53","author":"Sudhaker Rao","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib59","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.21873\/invivo.13186","article-title":"A pilot study of the association VDR polymorphisms with primary hyperparathyroidism","volume":"37","author":"Chorti","year":"2023","journal-title":"vivo"},{"key":"10.1016\/j.beem.2025.101985_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.631680","article-title":"Integrated whole-exome and transcriptome sequencing of sporadic parathyroid adenoma","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2025.101985_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.855181","article-title":"Astronauts plasma-derived exosomes induced aberrant EZH2-mediated H3K27me3 epigenetic regulation of the Vitamin D receptor","volume":"9","author":"Bisserier","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13095","article-title":"1,25-Dihydroxyvitamin D protects against age-related osteoporosis by a novel VDR-Ezh2-p16 signal axis","volume":"19","author":"Yang","year":"2020","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark Res"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/jcrt.JCRT_1090_19","article-title":"Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: a review","volume":"17","author":"Gautam","year":"2021","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02181-7","article-title":"EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine","volume":"11","author":"Barazeghi","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib66","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib67","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.046789","article-title":"EZH2 is required for parathyroid and thymic development through differentiation of the third pharyngeal pouch endoderm","volume":"14","author":"Caprio","year":"2021","journal-title":"Dis Models Mech"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12022-021-09686-x","article-title":"Analyzing genetic differences between sporadic primary and secondary\/tertiary hyperparathyroidism by targeted next-generation panel sequencing","volume":"32","author":"Hong","year":"2021","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.beem.2025.101985_bib69","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","article-title":"Identification of somatic mutations in parathyroid tumors using whole-exome sequencing","volume":"97","author":"Cromer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/ERC-13-0497","article-title":"The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors","volume":"21","author":"Svedlund","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040876","article-title":"MicroRNA profile alterations in parathyroid carcinoma: latest updates and perspectives","volume":"14","author":"Wielog\u00f3rska","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2025.101985_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2016.10.035","article-title":"MicroRNAs in parathyroid physiopathology","volume":"456","author":"Vaira","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2025.101985_bib73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12020-015-0555-4","article-title":"Epigenetic alterations in human parathyroid tumors","volume":"49","author":"Verdelli","year":"2015","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.beem.2025.101985_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039767","article-title":"The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit","volume":"7","author":"Luzi","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/ERC-09-0134","article-title":"Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue","volume":"17","author":"Corbetta","year":"2010","journal-title":"Endocr-Relat Cancer"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib76","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1245\/s10434-010-1359-7","article-title":"Identification of differentially expressed microRNA in parathyroid tumors","volume":"18","author":"Rahbari","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.beem.2025.101985_bib77","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.3390\/ijms221910465","article-title":"Are non-coding RNAs useful biomarkers in parathyroid tumorigenesis?","volume":"22","author":"Aurilia","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib78","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/dbio.2001.0342","article-title":"Hoxa3 and pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis","volume":"236","author":"Su","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2025.101985_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1749-6632.2011.06221.x","article-title":"Transcription factors in parathyroid development: lessons from hypoparathyroid disorders","volume":"1237","author":"Grigorieva","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.beem.2025.101985_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2015.04.018","article-title":"Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1","volume":"411","author":"Han","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2002.01627.x","article-title":"Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism","volume":"57","author":"Correa","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2025.101985_bib82","doi-asserted-by":"crossref","first-page":"e4084","DOI":"10.1210\/clinem\/dgab374","article-title":"GCM2 silencing in parathyroid adenoma is associated with promoter hypermethylation and gain of methylation on histone 3","volume":"106","author":"Singh","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib83","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/jc.2007-1783","article-title":"Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study","volume":"93","author":"Maret","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101985_bib84","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1210\/clinem\/dgab626","article-title":"Aberrant epigenetic alteration of PAX1 expression contributes to parathyroid tumorigenesis","volume":"107","author":"Singh","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101985_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2015.04.018","article-title":"Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1","volume":"411","author":"Han","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"6794","key":"10.1016\/j.beem.2025.101985_bib86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/35019088","article-title":"GATA3 haplo-insufficiency causes human HDR syndrome","volume":"406","author":"Van Esch","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.beem.2025.101985_bib88","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","article-title":"Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal","volume":"26","author":"Bradley","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.beem.2025.101985_bib89","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/endocrines4010018","article-title":"Parathyroid carcinoma: update on pathogenesis and therapy","volume":"4","author":"Marini","year":"2023","journal-title":"Endocrines"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib90","first-page":"329","article-title":"Parathyroid cancer","volume":"4","author":"McClenaghan","year":"2015","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/jcm8030297","article-title":"Comparative gene expression profiles in parathyroid adenoma and normal parathyroid tissue","volume":"8","author":"Chai","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib92","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","article-title":"Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways","volume":"3","author":"Clarke","year":"2019","journal-title":"J Endocr Soc"},{"issue":"8","key":"10.1016\/j.beem.2025.101985_bib93","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.beem.2025.101985_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-016-0197-2","article-title":"5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma","volume":"8","author":"Barazeghi","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.beem.2025.101985_bib95","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/IJGM.S249970","article-title":"Genomics and transcriptomics: the powerful technologies in precision medicine","author":"Khodadadian","year":"2020","journal-title":"Int J Gen Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib96","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/ERC-17-0470","article-title":"Transcriptional profiling reveals distinct classes of parathyroid tumors in PHPT","volume":"25","author":"Koh","year":"2018","journal-title":"Endocr-Relat Cancer"},{"issue":"5","key":"10.1016\/j.beem.2025.101985_bib97","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/s12276-023-00968-4","article-title":"Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma","volume":"55","author":"Jo","year":"2023","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cen.12479","article-title":"Changes in parathyroid proteome in patients with primary hyperparathyroidism due to sporadic parathyroid adenomas","volume":"81","author":"Varshney","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2025.101985_bib99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40618-018-0958-1","article-title":"Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples","volume":"42","author":"Arya","year":"2019","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"10.1016\/j.beem.2025.101985_bib100","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1039\/C0MB00191K","article-title":"A proteomic approach to study parathyroid glands","volume":"7","author":"Giusti","year":"2011","journal-title":"Mol Biosyst"},{"issue":"4","key":"10.1016\/j.beem.2025.101985_bib101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ejendo\/lvad046","article-title":"In-depth proteomic signature of parathyroid carcinoma","volume":"188","author":"Kong","year":"2023","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X25000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:44:11Z","timestamp":1778816651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X25000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X25000181"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101985","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101985"}}